Page 2 - Best Non-Hodgkin's lymphoma doctors: TOP 74 doctors

Specialist in Non-Hodgkin's lymphoma with diverse training from Harvard to Turkish institutions – now practicing at Memorial Şişli Hospital.

• Board-certified in Internal Medicine and Hematology
• Member of European Society for Blood and Marrow Transplantation
• Trained in advanced bone marrow transplantation
• Completed Lymphoma Masterclass through Turkish Academy of Blood Science

Prof. Elke Jaeger is a top German oncologist specializing in Non-Hodgkin's lymphoma, recognized by Focus rating.

• 41 years of experience of experience in oncology and hematology
• Head of Oncology and Hematology at Nordwest Clinic
• Specializes in sarcoma and complex lymphoma cases
• Recognized as one of Germany's best oncologists

Director of the Lymphoma Unit at San Raffaele – Dr. Ferreri founded the Italian Lymphoma Foundation to advance lymphoma treatment.

• Deputy Director of Hematology Oncology with over 28 years of experience of experience
• Author of 300+ research papers on lymphoma treatment
• Member of top hematology and oncology associations worldwide
• Specializes in non-Hodgkin lymphomas with dedicated research focus

A senior bone marrow transplantation specialist for Non-Hodgkin's lymphoma, Dr. Shapira is trained at one of Israel's leading centers.

• Over 36 years of experience of experience in hematology
• Specialized in internal medicine at Hadassah Medical Center
• Senior physician in the Bone Marrow Transplantation department
• Focuses on this complex treatment approach

36 years of experience at Memorial Sloan Kettering Cancer Center – Dr. Joffe specializes in lymphoma and CLL treatment at Sourasky Medical Center.

• Advanced subspecialty training in lymphomas and CLL
• Managed clinical studies in new drugs and immunotherapy
• Member of rare lymphoma treatment physician groups
• Senior doctor in Hematology and Bone Marrow Transplantation

Dr. Ayhan Gulsan specializes in Non-Hodgkin's lymphoma, with extensive training in stem cell transplantation at prestigious institutions like Duke University and Fred Hutchinson Cancer Research Center.

• Over 25 years of experience of experience in hematology and stem cell transplantation
• Founder and manager of Gazi University's Adult Stem Cell Transplant Unit
• Member of the Turkish Hematology Association
• Published numerous research papers on hematopoietic stem cell transplantation

Dr. Kodchanut is a hematologist with specialized training in Non-Hodgkin's lymphoma, working as a pioneer hematologist at Huahin Hospital.

• Graduated with honors from Naresuan University
• Completed hematology fellowship at Thammasat University
• Member of the Pharmacy and Therapeutics Committee
• Co-authored research on cancer-associated venous thromboembolism

With 34 years of experience focused on oncohematology, Dr. Aviv brings deep expertise in treating Non-Hodgkin's lymphoma at Ichilov Clinic.

• Specializes in blood cancers and complex hematologic conditions
• Works at Sourasky Medical Center – a leading oncology hospital
• Dedicated to personalized treatment approaches for each patient

Dr. Dror Levin directs the children's hematology oncology department at Sourasky Medical Center – a leading expert in pediatric blood disorders.

• Specializes in treating bone and soft tissue cancers (sarcomas) in children
• Board-certified in pediatric hematology and oncology
• Trained at Rizzoli Orthopaedic Institute – a world leader in bone oncology
• Member of the Israeli Society of Pediatric Hematology-Oncology
• Coordinates treatment programs for clotting disorders in children

Dr. Yair has made significant contributions to hematology, particularly in chronic lymphocytic leukemia, with numerous awards and published research.

• Recipient of multiple prestigious awards, including the Young Investigator Research Prize and Klitzberg Oncology Award
• Member of both the Israeli and American Hematology Associations
• Extensive training in hematology at Tel Aviv Medical Center
• Published researcher with grants from the Israeli Science Foundation and others

Univ. Prof. Dr. Wolfgang Köstler is a leading expert in personalized cancer medicine, specializing in breast cancer and gynecologic malignancies.

• Over 22 years of experience of experience in medical oncology and internal medicine
• Specializes in targeted therapies and individualized cancer treatment
• Associate Professor at the Medical University of Vienna
• Deputy Head of the Clinical Division of Oncology
• Active in translational cancer research and biomarker development

Chief Physician of Oncology/Hematology at Klinikum Solingen – Dr. Fox leads a certified interdisciplinary cancer center.

• Specialized in chemotherapy, immunotherapy, and targeted therapies
• Qualified specialist in genetics with a focus on molecular diagnostics
• Active in molecular biology research for innovative treatments
• Member of German Society of Oncology and American Association for Cancer Research

Professor Drach leads the Multiple Myeloma and Malignant Lymphoma program at Vienna's University Hospital – one of Europe's largest. He combines clinical expertise with academic leadership.

• Specializes in Non-Hodgkin's lymphoma diagnosis and treatment optimization
• Published 120+ scientific papers on hematologic oncology
• Board member of Austrian Society of Hematology and Oncology
• Trained at MD Anderson Cancer Center in Houston

Dr. Eckhart Weidmann heads the Hematology sector at Nordwest Clinic – specializing in blood disorder treatments with 36 years of experience of practice.

• Expert in Non-Hodgkin's lymphoma treatment
• Professor with extensive academic and clinical background
• Focuses on blood disorders at a leading hematology clinic

Dr. Alemdar specializes in Non-Hodgkin's lymphoma with extensive training in medical oncology at Akdeniz University.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Worked at Akdeniz University Hospital, a leading institution in Turkey
• Member of the Turkish Medical Oncology Association

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.